Pawel Kalinski

Immunobiology of human mucin 1 in a preclinical ovarian tumor model

A. Vlad, E. Elishaev, R. Budiu, 2013, Oncogene.

NK Receptors Replace CD28 As the Dominant Source of Signal 2 for Cognate Recognition of Cancer Cells by TAA-specific Effector CD8+ T Cells

S. Olejniczak, W. Storkus, N. Obermajer, 2023, Research square.

Systemic infusion of TLR3-ligand and IFN-α in patients with breast cancer reprograms local tumor microenvironments for selective CTL influx

M. Opyrchal, O. Maguire, Kathleen M Kokolus, 2023, Journal for ImmunoTherapy of Cancer.

Therapeutic Anti-Tumor Efficacy of DC-Based Vaccines Targeting TME-Associated Antigens Is Improved When Combined with a Chemokine-Modulating Regimen and/or Anti-PD-L1

D. Lowe, W. Storkus, Kathleen M Kokolus, 2024, Vaccines.

Breaking Barriers: Modulation of Tumor Microenvironment to Enhance Bacillus Calmette–Guérin Immunotherapy of Bladder Cancer

Pawel Kalinski, Omar M. Ibrahim, 2024, Cells.

MEETING HIGHLIGHTS: THE THIRD MARIE SKŁODOWSKA-CURIE SYMPOSIUM ON CANCER RESEARCH AND CARE AT ROSWELL PARK COMPREHENSIVE CANCER CENTER, BUFFALO, NY, SEPTEMBER 20-22, 2023.

M. Parascandola, E. Repasky, K. Suziedelis, 2023, Wiadomosci lekarskie.